Results 21 to 30 of about 31,797 (187)

Bullous Erythema Nodosum Leprosum Through the Dermoscope [PDF]

Dermatology Practical & Conceptual, 2022
Deepak Vashisht, Shekhar Neema, Durga Madhab Tripathy, Prashant Sengupta   +3 more
doaj   +2 more sources

Erythema nodosum leprosum limited to sun-exposed sites: An unusual presentation of type 2 lepra reaction

Journal of Clinical Sciences, 2017
The distribution of erythema nodosum leprosum lesions limited to sun-exposed sites is an unusual presentation of a type 2 reaction. We report the case of a 23-year-old female who presented with erythematous papules, nodules and plaques confined to sun ...
Ajay Kumar, Ashish Dalal, Sanjeev Gupta, Eshita Dadwal   +3 more
doaj   +2 more sources

Apremilast in Erythema Nodosum Leprosum: A Case Series

Journal of Dermatology and Dermatologic Surgery
Erythema nodosum leprosum (ENL) is an immune-mediated inflammatory reaction (antigen-antibody reaction involving complement) of leprosy. Available standard treatment in the form of steroids or thalidomide does not work in all ENL patients.
Usha Mandloi, Neha Gogia, Durgesh Sonare, Swagat Waghmare   +3 more
doaj   +2 more sources

Revealing Erythema Nodosum Leprosum in a Leprosy Patient: A Case of Treatment Noncompliance. [PDF]

Case Rep Infect Dis
Lepra reactions (LR) are acute inflammatory conditions with immune mediators that are highly morbid. Patients with the lepromatous end of the leprosy spectrum (BL‐LL) are the only ones who develop Type‐2 LR. 90% of the time, it happens during or right after treatment, usually within 2 years.
Alhariri B, Illahi MN, Elshaikh NAS, Omer RGM, AlQahtani N, Sharif M.   +5 more
europepmc   +2 more sources

Type 2 reaction associated sensorineural hearing loss in a drug resistant lepromatous leprosy patient: A case report

Asian Pacific Journal of Tropical Medicine, 2023
Rationale: Leprosy, a chronic granulomatous disease often present clinically as erythema nodosum leprosum, a type 2 reaction. The involvement of cochlear part of audiovestibular system is a rarity.
Harpreet Singh Pawar, Itu Singh, Harish Kumar Sagar   +2 more
doaj   +1 more source

The Type I Interferon Pathway Is Upregulated in the Cutaneous Lesions and Blood of Multibacillary Leprosy Patients With Erythema Nodosum Leprosum [PDF]

Frontiers in Medicine, 2022
Roberta O Pinheiro, Thyago Leal-Calvo, Veronica Schmitz   +2 more
exaly   +2 more sources

What is new in the pathogenesis and management of erythema nodosum leprosum

Indian Dermatology Online Journal, 2020
Erythema nodosum leprosum (ENL) is a manifestation of type II lepra reaction, seen in lepromatous or borderline lepromatous leprosy. Although it is a common reaction encountered in clinical practice, there are an increasingly large number of newer ...
Ramesh M Bhat, Tanvi P Vaidya
doaj   +1 more source

T-cell regulation in Erythema Nodosum Leprosum. [PDF]

PLoS Neglected Tropical Diseases, 2017
Leprosy is a disease caused by Mycobacterium leprae where the clinical spectrum correlates with the patient immune response. Erythema Nodosum Leprosum (ENL) is an immune-mediated inflammatory complication, which causes significant morbidity in affected ...
Edessa Negera, Stephen L Walker, Kidist Bobosha, Rawleigh Howe, Abraham Aseffa, Hazel M Dockrell, Diana N Lockwood   +6 more
doaj   +1 more source

Whole Blood Transcriptomics Reveals the Enrichment of Neutrophil Activation Pathways During Erythema Nodosum Leprosum Reaction [PDF]

Frontiers in Immunology
Maria Angela M Marques, Mariana de Andrea Hacker, Marcia de Berrêdo Pinho Moreira   +2 more
exaly   +2 more sources

Neutrophilic Leukocytosis and Erythema Nodosum Leprosum in Leprosy: Insights From a Retrospective Observational Study [PDF]

Frontiers in Immunology
Alice de Miranda Machado, Mariana de Andréa Hacker   +1 more
exaly   +2 more sources